Accurate Clinical Research

Lake Charles, Louisiana 70605

2 studies enrolling now · 10 studies all time

What they study most

Active Systemic Lupus Erythematosus, Arthritis, Autoimmune Diseases, Connective Tissue Diseases, Dendritic Cell -Mediated Rheumatic Diseases, Immune System Diseases, Joint Diseases, Lupus Nephritis, Musculoskeletal Diseases, Rheumatic Diseases, Rheumatoid Arthritis, Rheumatoid Arthritis (RA)

Studies at this site

• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Recruiting now
• A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
• Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) — Running, not enrolling
• The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis — Completed
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis — Running, not enrolling
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases — Completed
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early